MX2024004570A - Tabletas de dextrosa de multiples capas. - Google Patents

Tabletas de dextrosa de multiples capas.

Info

Publication number
MX2024004570A
MX2024004570A MX2024004570A MX2024004570A MX2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A MX 2024004570 A MX2024004570 A MX 2024004570A
Authority
MX
Mexico
Prior art keywords
layered
dextrose
tablet
tablets
dextrose tablets
Prior art date
Application number
MX2024004570A
Other languages
English (en)
Spanish (es)
Inventor
Helle Wittorff
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Publication of MX2024004570A publication Critical patent/MX2024004570A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2024004570A 2021-10-15 2022-10-12 Tabletas de dextrosa de multiples capas. MX2024004570A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/502,322 US20230123099A1 (en) 2021-10-15 2021-10-15 Dextrose tablets with improved mouthfeel
PCT/DK2022/050215 WO2023061544A1 (en) 2021-10-15 2022-10-12 Multi-layered dextrose tablets

Publications (1)

Publication Number Publication Date
MX2024004570A true MX2024004570A (es) 2024-04-30

Family

ID=84047794

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024004570A MX2024004570A (es) 2021-10-15 2022-10-12 Tabletas de dextrosa de multiples capas.

Country Status (9)

Country Link
US (2) US20230123099A1 (cg-RX-API-DMAC10.html)
EP (2) EP4415686A1 (cg-RX-API-DMAC10.html)
JP (2) JP2024538788A (cg-RX-API-DMAC10.html)
KR (1) KR20240072292A (cg-RX-API-DMAC10.html)
CN (2) CN118103029A (cg-RX-API-DMAC10.html)
AU (2) AU2022367650B2 (cg-RX-API-DMAC10.html)
CA (2) CA3175564A1 (cg-RX-API-DMAC10.html)
MX (1) MX2024004570A (cg-RX-API-DMAC10.html)
WO (2) WO2023061544A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK202430540A1 (en) * 2024-09-12 2026-03-26 Fertin Pharma As Orally disintegrating nicotine tablet with reduced sweetener content

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US20020122823A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Soft tablet containing dextrose monohydrate
DK2792363T3 (da) * 2003-08-26 2016-09-26 Shire Biopharmaceuticals Holdings Ireland Ltd Farmaceutisk formulering, der omfatter lanthanforbindelser
US8758814B2 (en) * 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
EP2178522A1 (en) * 2007-07-11 2010-04-28 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
JP5623275B2 (ja) * 2007-07-31 2014-11-12 カーギル インコーポレイテッド 直接打錠可能なデキストロース
US20120034302A1 (en) * 2009-02-11 2012-02-09 Liangping Yu Particulate composition and the method of making the same
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
US8858210B2 (en) * 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
CN101856121B (zh) * 2010-05-19 2012-05-23 北京联合大学生物化学工程学院 一种咀嚼片及其制备方法
NZ611467A (en) * 2010-12-02 2015-06-26 Aptalis Pharmatech Inc Rapidly dispersing granules, orally disintegrating tablets and methods
US10632076B2 (en) * 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
KR102037205B1 (ko) * 2018-02-14 2019-10-28 경기도 양평군(양평군 농업기술센터장) 밀크씨슬과 흰꽃무지 굼벵이를 이용한 기능성 식품의 제조방법

Also Published As

Publication number Publication date
AU2022367650A1 (en) 2024-03-14
WO2023061543A1 (en) 2023-04-20
JP2024538788A (ja) 2024-10-23
EP4415686A1 (en) 2024-08-21
US20240415775A1 (en) 2024-12-19
CA3232753A1 (en) 2023-04-20
JP2024538789A (ja) 2024-10-23
EP4415687A1 (en) 2024-08-21
CN118103028A (zh) 2024-05-28
CA3175564A1 (en) 2023-04-15
US20230123099A1 (en) 2023-04-20
AU2022367650B2 (en) 2025-10-23
AU2022363912A1 (en) 2024-03-14
AU2022363912B2 (en) 2025-10-30
WO2023061544A1 (en) 2023-04-20
CN118103029A (zh) 2024-05-28
KR20240072292A (ko) 2024-05-23

Similar Documents

Publication Publication Date Title
EP4563151A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A KRAS G12D INHIBITOR
ECSP088490A (es) Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico
GT200600295A (es) Una formulacion solida de dosificacion farmaceutica
CO2020008825A2 (es) Regímenes de dosificación superior de g1t38
ME02189B (me) Farmaceutski dozni oblici sa kontrolisanim oslobađanjem
BRPI0620863A8 (pt) comprimido em camadas com combinação de liberação tripla
MX2021012712A (es) Tabletas de cannabinoides de desintegracion rapida.
AR062721A1 (es) Composicion farmaceutica de liberacion modificada para administracion oral que comprende una pluralidad de mini- comprimidos con un inhibidor del factor xa, su uso para prpeparar un medicamento y proceso para prepararla
MX2021010988A (es) Derivados de insulina sensibles a la glucosa.
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
PA8809601A1 (es) Combinación anti-retroviral
MX2020007322A (es) Indicador biologico.
CL2020000959A1 (es) Formulación de tableta farmacéutica de dos capas
CO2024002256A2 (es) Formas de dosificación gastrorretentivas de 5-hidroxitriptófano
MX2023012535A (es) Composicion oral efervescente.
CO6321223A2 (es) Formulacion farmaceutica solida que contiene ciclostazol
CO5640087A2 (es) Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos
AR115913A1 (es) Formas de dosificación oral biodisponibles, uso, métodos
CO2022018623A2 (es) Composiciones farmacéuticas que contienen sustancias liberadoras de enterocinas en múltiples formas de dosificación combinadas con agentes gelificantes
PE20081191A1 (es) Combinacion farmaceutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
AR057932A1 (es) Comprimido bicapa que comprende telmisartan y diuretico
PE20081637A1 (es) Composicion farmaceutica que contiene tramadol y ketoprofeno en asociacion
DOP2025000156A (es) Composición farmacéutica que comprende enavogliflozina y metformina
AR061487A1 (es) Una composicion farmaceutica en forma de comprimido multicapa de tetraciclina